The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.

Abidi, S M; Howard, E W; Dmytryk, J J; Pento, J T

Abidi, S M; Howard, E W; Dmytryk, J J; Pento, J T.

Affiliation

Abidi SM; Department of Pharmacology and Toxicology, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.

Clin Exp Metastasis ; 16(3): 235-41, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9568641

Subject(s)

Breast Neoplasms/enzymology; Estrogen Antagonists/pharmacology; Neoplasm Invasiveness; Urokinase-Type Plasminogen Activator/metabolism; Estradiol/analogs & derivatives; Estradiol/pharmacology; Female; Fibronectins/metabolism; Fulvestrant; Humans; Tamoxifen/analogs & derivatives; Tamoxifen/pharmacology; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Urokinase-Type Plasminogen Activator / Estrogen Antagonists / Neoplasm Invasiveness Limits: Female / Humans Language: En Journal: Clin Exp Metastasis Journal subject: NEOPLASIAS Year: 1998 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links